These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 12046386

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Esophageal epithelial cells renewal in evaluation of the pariet efficacy in the treatment of patients with reflux esophagitis].
    Osadchuk MA, Lipatova TE, Chaplygin NV.
    Eksp Klin Gastroenterol; 2002; (4):23-6, 131. PubMed ID: 12503269
    [Abstract] [Full Text] [Related]

  • 3. [Inhibitors of proton pump in the treatment of non-ulcer functional dyspepsia of the reflux-like type].
    Ivanova NG.
    Eksp Klin Gastroenterol; 2002; (2):35-6, 101. PubMed ID: 12046384
    [Abstract] [Full Text] [Related]

  • 4. [Regeneration of the gastric epitheliocytes during treatment of duodenal ulcer with pariet].
    Kulidzhanov AIu, Usik SF, Osadchuk MA, Kvetnoĭ IM, Kheĭlyk AI.
    Voen Med Zh; 2002 Apr; 323(4):38-42. PubMed ID: 12046531
    [No Abstract] [Full Text] [Related]

  • 5. [Graded therapy in reflux disease. "In severe cases 40 mg., in milder 20 mg."].
    Gillessen A.
    MMW Fortschr Med; 2004 Mar 11; 146(11):54. PubMed ID: 15152771
    [No Abstract] [Full Text] [Related]

  • 6. Proton pump inhibitors.
    Grover JK, Vats V.
    Trop Gastroenterol; 1999 Mar 11; 20(1):16-28. PubMed ID: 10464444
    [No Abstract] [Full Text] [Related]

  • 7. [Proton pump inhibitors in the treatment of reflux esophagitis].
    Bigard MA.
    Rev Prat; 1994 Oct 01; 44(15):1992-6. PubMed ID: 7984887
    [No Abstract] [Full Text] [Related]

  • 8. [Pariet in current patterns of eradication of Helicobacter pylori infection].
    Baranskaia EK.
    Voen Med Zh; 2001 Apr 01; 322(4):54-8. PubMed ID: 11547668
    [No Abstract] [Full Text] [Related]

  • 9. [A case of the successful treatment of the esophageal leukoplakia with rabeprazole].
    Arutiunov AG, Burkov SG, Burdina EG, Svirchev VV.
    Eksp Klin Gastroenterol; 2002 Apr 01; (4):38-9, 131. PubMed ID: 12503273
    [Abstract] [Full Text] [Related]

  • 10. [Effectiveness of pariet (rabeprazole) in the treatment of gastroesophageal reflux disease (at the reflux-esophagitis stage)].
    Vasil'ev IuV, Noskova KK, Zelenikin SA.
    Eksp Klin Gastroenterol; 2002 Apr 01; (1):55-60, 190. PubMed ID: 12271586
    [Abstract] [Full Text] [Related]

  • 11. Balanced perspective essential in erosive oesophagitis treatment.
    Gillessen A.
    Aliment Pharmacol Ther; 2005 Nov 01; 22(9):889-90; author reply 890-1. PubMed ID: 16225500
    [No Abstract] [Full Text] [Related]

  • 12. [Long-term maintenance treatment of reflux esophagitis resistant to H2-RA with PPI (lansoprazole)].
    Endo M, Sugihara K.
    Nihon Rinsho; 2000 Sep 01; 58(9):1865-70. PubMed ID: 11004817
    [Abstract] [Full Text] [Related]

  • 13. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A, Stimac D, Vceva A, Rubinić M, Ivandić A, Ivanis N, Horvat D, Volarić M, Karner I.
    Acta Med Croatica; 1997 Sep 01; 51(3):171-4. PubMed ID: 9248117
    [Abstract] [Full Text] [Related]

  • 14. [Some comparative aspects of treating the gastroesophageal reflux disease eradication].
    Minushkin ON, Maslovskiĭ LV, Anikina NIu.
    Eksp Klin Gastroenterol; 2004 Sep 01; (3):45-8, 104. PubMed ID: 15560401
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of the efficacy of pariet in patients with gastroesophageal reflux disease with thoracic pain not connected with cardiac disease].
    Maev IV, Kucheriavyĭ IuA, Danilin MS.
    Eksp Klin Gastroenterol; 2003 Sep 01; (5):10-2, 192. PubMed ID: 14621603
    [Abstract] [Full Text] [Related]

  • 16. [Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short-term therapy. Preliminary report].
    Córdova-Villalobos JA, Ramírez-Barba EJ, Ramírez-Covarrubias JC.
    Rev Gastroenterol Mex; 1996 Sep 01; 61(4):306-9. PubMed ID: 9072780
    [Abstract] [Full Text] [Related]

  • 17. Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn.
    DeVault KR.
    Aliment Pharmacol Ther; 2006 Mar 01; 23 Suppl 1():33-9. PubMed ID: 16483268
    [Abstract] [Full Text] [Related]

  • 18. Proton pump inhibitors: cost-effective agents for management of reflux-induced esophagitis.
    Gregor JC.
    Am J Manag Care; 2000 Aug 01; 6(8):934-5. PubMed ID: 11186505
    [No Abstract] [Full Text] [Related]

  • 19. Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux.
    Calabrese C, Fabbri A, Bortolotti M, Cenacchi G, Carlo S, Zahlane D, Miglioli M, Di Febo G.
    World J Gastroenterol; 2005 Mar 28; 11(12):1876-80. PubMed ID: 15793885
    [Abstract] [Full Text] [Related]

  • 20. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
    Katz PO.
    Rev Gastroenterol Disord; 2006 Mar 28; 6(3):136-45. PubMed ID: 16957654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.